nach oben

Archives of Virology

Erschienen in:

01.08.2008 | Brief Review

Recombinant porcine endogenous retroviruses (PERV-A/C): a new risk for xenotransplantation?

verfasst von: Joachim Denner

Erschienen in: Archives of Virology | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

PERVs are integrated in the genome of all pigs. Some of them infect human cells and represent therefore a potential risk for xenotransplantation using pig cells or organs. Three replication-competent subtypes have been described, PERV-A, PERV-B and PERV-C. Whereas PERV-A and PERV-B are polytropic viruses and infect, among others, human cells, PERV-C is an ecotropic virus, infecting only pig cells. Recombinant PERV-A/C are able to infect human cells, they are characterised by high-titre replication and their proviruses have been found de novo integrated in the genome of somatic pig cells, but not in the germ line. This review compares recombinant PERVs with other recombinant retroviruses in order to evaluate their potential pathogenicity.

Sachs DH, Sykes M, Robson SC, Cooper DK (2001) Xenotransplantation. Adv Immunol 79:129–223PubMedCrossRef

Tucker A, Belcher C, Moloo B, Bell J, Mazzulli T, Humar A, Hughes A, McArdle P, Talbot A (2002) The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation 9:191–202PubMedCrossRef

Denner J (1998) Immunosuppression by retroviruses: implications for xenotransplantation. Ann NY Acad Sci 862:75–86PubMedCrossRef

Denner J (2007) Transspecies transmissions of retroviruses: new cases. Virology 369:229–233PubMedCrossRef

Le Tissier P, Stoye JP, Takeuchi Y, Patience C, Weiss RA (1997) Two sets of human-tropic pig retrovirus. Nature 389:681–682PubMedCrossRef

Patience C, Switzer WM, Takeuchi Y, Griffiths DJ, Goward ME, Heneine W, Stoye JP, Weiss RA (2001) Multiple groups of novel retroviral genomes in pigs and related species. J Virol 75:2771–2775PubMedCrossRef

Ericsson T, Oldmixon B, Blomberg J, Rosa M, Patience C, Andersson G (2001) Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol 75:2765–2770PubMedCrossRef

Mang R, Maas J, Chen X, Goudsmit J, van der Kuyl AC (2001) Identification of novel type C porcine endogenous retrovirus: evidence that copy number of endogenous retrovirus increases during host inbreeding. J Gen Virol 82:1829–1834PubMed

Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P (1998) Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 72:3082–3087PubMed

10.

Wilson CA, Wong S, Van Brocklin M, Federspiel MJ (2000) Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 74:49–56PubMed

11.

Martin U, Kiessig V, Blusch JH, Haverich A, Von der Helm K, Herden T, Steinhoff G (1998) Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 352:692–694PubMedCrossRef

12.

Tacke SJ, Specke V, Denner J (2003) Differences in release and determination of subtype of porcine endogenous retroviruses produced by stimulated normal pig blood cells. Intervirology 46:17–24PubMedCrossRef

13.

Tacke SJ, Kurth R, Denner J (2000) Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 268:87–93PubMedCrossRef

14.

McIntyre MC, Kannan B, Solano-Aguilar GI, Wilson CA, Bloom ET (2003) Detection of porcine endogenous retrovirus in cultures of freshly isolated porcine bone marrow cells. Xenotransplantation 10:337–342PubMedCrossRef

15.

Dieckhoff B, Puhlmann J, Büscher K, Hafner-Marx A, Herbach N, Bannert N, Büttner M, Wanke R, Kurth R, Denner J (2007) Expression of porcine endogenous retroviruses PERVs in melanomas of Munich miniature swine MMS troll. Vet Microbiol 123:53–68PubMedCrossRef

16.

Suzuka I, Shimizu N, Sekiguchi K, Hoshino H, Kodama M, Shimotohno K (1986) Molecular cloning of unintegrated closed circular DNA of porcine retrovirus. FEBS Lett 198:339–343PubMedCrossRef

17.

Moennig V, Frank H, Hunsmann G, Ohms P, Schwarz H, Schäfer W (1974) C-type particles produced by a permanent cell line from a leukemic pig. II. Physical, chemical and serological characterization of the particles. Virology 57:179–188PubMedCrossRef

18.

Frazier ME (1985) Evidence for retrovirus in miniature swine with radiation-induced leukemia or metaplasia. Arch Virol 83:83–97PubMedCrossRef

19.

Patience C, Takeuchi Y, Weiss WA (1997) Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282–286PubMedCrossRef

20.

Martin U, Winkler ME, Id M, Radeke H, Arseniev L, Takeuchi Y, Simon AR, Patience C, Haverich A, Steinhoff G (2000) Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 7:138–142PubMedCrossRef

21.

Specke V, Rubant S, Denner J (2001) Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 285:177–180PubMedCrossRef

22.

Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoye JP (1998) Infection of human cells by an endogenous retrovirus of pigs. J Virol 72:9986–9991

23.

Specke V, Boller K, Schwendemann J, Denner J (2001) Porcine endogenous retroviruses (PERVs): In vitro host range and attempts to establish small animal models. J Gen Virol 82:837–844PubMed

24.

Specke V, Schuurman HJ, Plesker R, Coulibaly C, Özel M, Langford G, Kurth R, Denner J (2002) Virus safety in xenotransplantation: preliminary data from first small animal and non-human primate in vivo experiments. Transpl Immunol 9:281–288PubMedCrossRef

25.

Specke V, Plesker R, Coulibaly C, Boller K, Denner J (2002) Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) and lack of transmission to minks in vivo. Arch Virol 147:305–319PubMedCrossRef

26.

Blusch JH, Patience C, Takeuchi Y, Templin C, Roos C, Von Der Helm K, Steinhoff G, Martin U (2000) Infection of nonhuman primate cells by pig endogenous retrovirus. J Virol 74:7687–7690PubMedCrossRef

27.

Ericsson TA, Takeuchi Y, Templin C, Quinn G, Farhadian SF, Wood JC, Oldmixon BA, Suling KM, Ishii JK, Kitagawa Y, Miyazawa T, Salomon DR, Weiss RA, Patience C (2003) Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci 100:6759–6764PubMedCrossRef

28.

Mattiuzzo G, Matouskova M, Takeuchi Y (2007) Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Retrovirology 4(1):93PubMedCrossRef

29.

Valérie C, Salemi M, Pourrut X, Mpoudi-Ngole E, Abela B, Auzel P, Bibollet-Ruche F, Hahn B, Vandamme AM, Delaporte E, Peeters M (2002) Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. J Virol 76:8298–8309

30.

Paraskevis D, Lemey P, Salemi M, Suchard M, Van de Peer Y, Vandamme AM (2003) Analysis of the evolutionary relationships of HIV-1 and SIVcpz sequences using bayesian inference: implications for the origin of HIV-1. Mol Biol Evol 20:1986–1996PubMedCrossRef

31.

Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BN (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436–441PubMedCrossRef

32.

De Leys R, Vanderborght B, van den Haesevelde M, Heyndrickx L, van Geel A, Wauters C, Bernaerts R, Saman E, Nijs P, Willems B (1990) Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central Africa origin. J Virol 64:1207–1216PubMed

33.

Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsaque JM, Kaptue L (1994) A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 68:1581–1585PubMed

34.

Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin MC, Saragosti S, Georges-Courbot MC, Barré-Sinoussi F, Brun-Vézinet F (1998) Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 4:1032–1037PubMedCrossRef

35.

Charneau P, Borman AM, Quillent C, Guetard D, Chamaret S, Cohen J, Rémy G, Montagnier L, Clavel F (1994) Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 205:247–253PubMedCrossRef

36.

Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, Sema H, Tshimanga K, Bongo B, Delaporte E (2000) Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 74:10498–10507PubMedCrossRef

37.

Murphy E, Korber B, Georges-Courbot MC, You B, Pinter A, Cook D, Kieny MP, Georges A, Mathiot C, Barré-Sinoussi F (1993) Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses 9:997–1006PubMedCrossRef

38.

Yang C, Dash B, Hanna SL, Frances HS, Nzilambi N, Colebunders RC, St Louis M, Quinn TC, Folks TM, Lal RB (2001) Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses 17:361–36

39.

Konings FA, Burda ST, Urbanski MM, Zhong P, Nadas A, Nyambi PN (2006) Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. J Med Virol 78(5):523–534PubMedCrossRef

40.

Motomura K, Chen J, Hu WS (2008) Genetic recombination between human immunodeficiency virus type 1 (HIV-1) and HIV-2, two distinct human lentiviruses. J Virol 82(4):1923–1933 [Epub 2007 Dec 5]

41.

Roy-Burman P (1995) Endogenous env elements: partners in generation of pathogenic feline leukemia viruses. Virus Genes 11(2–3):147–161PubMedCrossRef

42.

Mendoza R, Anderson MM, Overbaugh J (2006) A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J Virol 80:3378–3385PubMedCrossRef

43.

Anderson MM, Lauring AS, Robertson S, Dirks C, Overbaugh J (2001) Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses. J Virol 75:10563–10572PubMedCrossRef

44.

Takeuchi Y, Vile RG, Simpson G, O’Hara B, Collins MK, Weiss RA (1992) Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol 66(2):1219–1222PubMed

45.

Fan H (1997) Leukemogenesis by Moloney murine leukemia virus: a Multistep process. Trends Microbiol 5(2):74–82PubMedCrossRef

46.

Villanueva RA, Campbell S, Roth MJ (2003) Molecular analysis of a recombinant M- MuLV/RaLV retrovirus. Virology 315(1):195–208PubMedCrossRef

47.

Hu WS, Temin HM (1990) Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 87(4):1556–1560PubMedCrossRef

48.

Han JY, Cannon PM, Lai KM, Zhao Y, Eiden MV, Anderson WF (1997) Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. J Virol 71:8103–8108PubMed

49.

Denner J, Specke V, Thiesen U, Karlas A, Kurth R (2003) Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus PERV during passage in human cells. Virology 314:125–133PubMedCrossRef

50.

Scheef G, Fischer N, Krach U, Tönjes R (2001) The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells. J Virol 75:6933–6940PubMedCrossRef

51.

Harrison I, Takeuchi Y, Bartosch B, Stoye JP (2004) Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol 78:13871–13879PubMedCrossRef

52.

Oldmixon BA, Woods JC, Ericsson TA, Wilson CA, White-Scharf ME, Andersson G, Greenstein JL, Schuurmann HJ, Patience C (2002) Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 76:3045–3048PubMedCrossRef

53.

Wood JC, Quinn G, Suling KM, Oldmixon BA, Van Tine BA, Cina R, Arn S, Huanq CA, Scobie L, Onions DE, Sachs DH, Schuurmann HJ, Fishman JA, Patience C (2004) Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. J Virol 78:2494–2501PubMedCrossRef

54.

Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, Takeuchi Y (2004) Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 78:13880–13890PubMedCrossRef

55.

Martin SI, Wilkinson R, Fishman JA (2006) Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. Virol J 3:91–96PubMedCrossRef

56.

Lavillette D, Kabat D (2004) Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation. J Virol 78(16):8868–8877PubMedCrossRef

57.

Barnett AL, Wensel WL, Li W, Fass D, Cunningham JM (2003) Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J Virol 77:2717–2729PubMedCrossRef

58.

Wensel DL, Li W, Cunningham JM JM (2003) A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses. J Virol 77:3460–3469PubMedCrossRef

59.

Gemeniano M, Mpanju O, Salomon DR, Eiden MV, Wilson CA (2006) The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-terminal region of its surface envelope protein. Virology 346:108–117PubMedCrossRef

60.

Perryman S, Nishio J, Chesebro B (1991) Complete nucleotide sequence of Friend murine leukemia virus, strain FB29. Nucleic Acids Res 19:6950PubMedCrossRef

61.

Donahue PR, Hoover EA, Beltz GA, Riedel N, Hirsch VM, Overbaugh J, Mullins JI (1988) Strong sequence conservation among horizontally transmissible minimally pathogenic feline leukemia viruses. J Virol 62:722–731PubMed

62.

Fiebig U, Hartmann MG, Bannert N, Kurth R, Denner J (2006) Transspecies transmission of the endogenous koala retrovirus. J Virol 80:5651–5654PubMedCrossRef

63.

Delassus S, Sonigo P, Wain-Hobson S (1989) Genetic organization of gibbon ape leukemia virus. Virology 173:205–213PubMedCrossRef

Titel: Recombinant porcine endogenous retroviruses (PERV-A/C): a new risk for xenotransplantation?
verfasst von: Joachim Denner
Publikationsdatum: 01.08.2008
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 8/2008
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-008-0141-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Recombinant porcine endogenous retroviruses (PERV-A/C): a new risk for xenotransplantation?

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2008

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments

Genetic study of hepatitis B virus in Indonesia reveals a new subgenotype of genotype B in east Nusa Tenggara

Genetic analysis of H9N2 avian influenza viruses isolated from India

Inactivation and morphological changes of avian influenza virus by copper ions

Complete genome sequence of a virulent isolate of Arabis mosaic virus from privet (Ligustrum vulgare)

Porcine reproductive and respiratory syndrome virus modulates apoptosis during replication in alveolar macrophages

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin